BACKGROUND AND PURPOSE: Uncertain prognosis and modest treatment efficacy make multiple sclerosis (MS) a particularly difficult disease to adjust to for both patients and their significant others (SOs). Few studies have assessed health-related quality of life (HRQOL) and depressive symptoms in SOs of people with MS in the community. We assessed, and identified predictors of, HRQOL and depression in SOs of adults with MS. METHODS: POSMOS (postal survey of self-assessed health in MS adults and SOs) is a longitudinal survey on a random sample of 251 people with MS in the Milan area. In 2010, SOs and contemporaneous controls completed the SF-36 and Chicago Multiscale Depression Inventory (CMDI). RESULTS: Overall, 142 SOs (mean age 53.1 years; 50% women, 65% partners) and 120 controls (similar to SOs for sex and education, but older) participated. By multivariable modeling of the SO plus control population, SF-36 vitality was lower in SOs (proportional odds ratio 0.45; 95% confidence interval 0.28-0.70), women (0.41; 0.27-0.64), and older subjects (0.98; 0.97-0.99). SF-36mental health was also lower in SOs (0.62; 0.40-0.96) and women (0.43; 0.28-0.67). Regarding MS characteristics associated with HRQOL and depression in SOs, severe disability [Expanded Disability Status Scale (EDSS > 6.5)] had no effect, whilst depressive symptoms (pathologic CMDI) negatively influenced most SF-36 and all CMDI scores in SOs. CONCLUSIONS: SOs had significantly lower vitality and psychological well-being than controls, identifying a burden in being the companion of a person with MS. This burden was unrelated to physical compromise but associated with depressive symptoms in MS.
RCT Entities:
BACKGROUND AND PURPOSE: Uncertain prognosis and modest treatment efficacy make multiple sclerosis (MS) a particularly difficult disease to adjust to for both patients and their significant others (SOs). Few studies have assessed health-related quality of life (HRQOL) and depressive symptoms in SOs of people with MS in the community. We assessed, and identified predictors of, HRQOL and depression in SOs of adults with MS. METHODS: POSMOS (postal survey of self-assessed health in MS adults and SOs) is a longitudinal survey on a random sample of 251 people with MS in the Milan area. In 2010, SOs and contemporaneous controls completed the SF-36 and Chicago Multiscale Depression Inventory (CMDI). RESULTS: Overall, 142 SOs (mean age 53.1 years; 50% women, 65% partners) and 120 controls (similar to SOs for sex and education, but older) participated. By multivariable modeling of the SO plus control population, SF-36 vitality was lower in SOs (proportional odds ratio 0.45; 95% confidence interval 0.28-0.70), women (0.41; 0.27-0.64), and older subjects (0.98; 0.97-0.99). SF-36 mental health was also lower in SOs (0.62; 0.40-0.96) and women (0.43; 0.28-0.67). Regarding MS characteristics associated with HRQOL and depression in SOs, severe disability [Expanded Disability Status Scale (EDSS > 6.5)] had no effect, whilst depressive symptoms (pathologic CMDI) negatively influenced most SF-36 and all CMDI scores in SOs. CONCLUSIONS: SOs had significantly lower vitality and psychological well-being than controls, identifying a burden in being the companion of a person with MS. This burden was unrelated to physical compromise but associated with depressive symptoms in MS.
Authors: Gillian G Leibach; Marilyn Stern; Adriana Aguayo Arelis; Miguel Angel Macias Islas; Brenda Viridiana Rábago Barajas Journal: Int J MS Care Date: 2016 Jan-Feb
Authors: Kristina Gottberg; C Chruzander; U Einarsson; S Fredrikson; S Johansson; L Widén Holmqvist Journal: BMJ Open Date: 2014-12-16 Impact factor: 2.692
Authors: Sara Carletto; Martina Borghi; Diana Francone; Francesco Scavelli; Gabriella Bertino; Marco Cavallo; Simona Malucchi; Antonio Bertolotto; Francesco Oliva; Luca Ostacoli Journal: BMC Neurol Date: 2016-01-13 Impact factor: 2.474
Authors: Claudia Borreani; Elisabetta Bianchi; Erika Pietrolongo; Ilaria Rossi; Sabina Cilia; Miranda Giuntoli; Andrea Giordano; Paolo Confalonieri; Alessandra Lugaresi; Francesco Patti; Maria Grazia Grasso; Laura Lopes de Carvalho; Lucia Palmisano; Paola Zaratin; Mario Alberto Battaglia; Alessandra Solari Journal: PLoS One Date: 2014-10-06 Impact factor: 3.240
Authors: Paul B Perrin; Ivan Panyavin; Alejandra Morlett Paredes; Adriana Aguayo; Miguel Angel Macias; Brenda Rabago; Sandra J Fulton Picot; Juan Carlos Arango-Lasprilla Journal: Behav Neurol Date: 2015-10-11 Impact factor: 3.342